abstract |
The phenyltetrazole derivative of formula (I), and its pharmaceutically acceptable salt, are plasma calicrane inhibitors useful in the treatment of eye diseases, especially in the treatment of diabetic macular edema, age-related macular degeneration and choroidal neovascularization. Is. |